The Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy

BACKGROUND AND PURPOSE: Nelonemdaz (Neu2000) has both selective antagonism against 2B subunit of N-methyl-D-aspartate receptor and antioxidant activity. This drug provides sufficient evidence of neuroprotection in acute cerebral ischemia/reperfusion models. This phase III trial aims to determine thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jin Soo, Lee, Ji Sung, Gwag, Byoung Joo, Choi, Dennis W., An, Chun San, Kang, Hyun Goo, Song, Tae-Jin, Ahn, Seong Hwan, Kim, Chang Hun, Shin, Dong-Ick, Kwon, Sun U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Stroke Society 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911845/
https://www.ncbi.nlm.nih.gov/pubmed/36746385
http://dx.doi.org/10.5853/jos.2022.02453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911845/
https://www.ncbi.nlm.nih.gov/pubmed/36746385
http://dx.doi.org/10.5853/jos.2022.02453

Ejemplares similares